GENBIOMA

Genbioma is a biotech company specializing in the research, development, and commercialization of innovative solutions in microbiome-based nutraceuticals. The company's primary focus is on studying the effectiveness of probiotic strains and their ability to modulate the intestinal microbiota to improve metabolic dysfunctions. The objective is to provide natural nutritional solutions that can differentially enhance short and long-term factors to prevent the development of pathologies such as diabetes, cardiovascular risk, and obesity by studying the impact on the intestinal microbiota.